Default company panoramic image

Allovate, LLC

A specialty pharmaceutical company developing an improved approach to allergy immunotherapy for treating allergic diseases - no more shots

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location New York City, NY, USA
  • Currency USD
  • Founded February 2012
  • Employees 2
  • Website

Company Summary

Allovate's product platform is AllerDent™, an improved and patient-friendly mode of immunotherapy (IT). IT is the only disease-modifying treatment that can address the underlying causes for the US's 60M allergy sufferers. A number of issues conspire to limit IT effectiveness, particularly compliance. AllerDent seamlessly integrates patients’ daily IT administration with the ritual of daily dental care (tooth brushing), a habitual behavior.


  • Default avatar
    Erick Berglund
    Chief Executive Officer

    Dr. Berglund received his BS and MS from the University of N.H. and Boston University School of Medicine, respectively, and his PhD in biochemistry from Goethe University, Germany. He was a researcher at Sanofi‐Aventis, a USPTO registered patent agent, Medical Strategy Director at H4B Chelsea, a global healthcare communications consultancy, business development and strategy at Kyorin Pharmaceuticals, and CEO of Vaxiva KK, a Tokyo vaccine company.

  • Default avatar
    Michael Nelson
    Chief Financial Officer

    Mr. Nelson graduated from Cornell University and received his J.D. from New York University School of Law. Previously, he was CFO & GC of an early stage healthcare company, an analyst at Barclays Capital and ING, an investment banker at CIBC World Markets and practiced law at Willkie Farr & Gallagher and Dewey Ballantine. Mr. Nelson is managing director and head of healthcare at Westwood Capital, LLC and president of Thea Capital Management, LLC.

  • Default avatar
    William Reisacher
    Chief Scientific Advisor

    Dr. Reisacher graduated from Cornell University and received his medical degree from Mount Sinai School of Medicine with distinction in research. His clinical expertise lies in the diagnosis and management of airborne and food allergies in adults and children. Dr. Reisacher is a General Otolaryngologist and Otolaryngic Allergist on the fulltime faculty of Weill Cornell Medical College, where he is Associate Professor and the Director of Allergy.


  • Default avatar
    Andrew Abramowitz, PLLC
    Default avatar
    John R. Lieberman, CPA